| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vericel Corp | Director | Common Stock | 11K | $455K | $41.36 | Oct 16, 2024 | Direct |
| Akebia Therapeutics, Inc. | Director | Common Stock | 153K | $400K | $2.62 | Jun 10, 2025 | Direct |
| CONTRAFECT Corp | Director | Options (Right to Buy) | 42K | $141K | $3.35 | May 17, 2022 | Direct |
| SCYNEXIS INC | Director | Common stock | 70K | $67.2K | $0.96 | Jun 26, 2025 | Direct |
| Vericel Corp | Director | Restricted Stock Unit | 3.2K | $57.6K | $18.00 | May 1, 2024 | Direct |
| Akebia Therapeutics, Inc. | Director | Stock Option (Right to buy) | 53.6K | Jun 10, 2025 | Direct | ||
| SCYNEXIS INC | Director | Stock Option | 23K | Jun 26, 2025 | Direct | ||
| Vericel Corp | Director | Stock Option (Right to Buy) | 0 | Oct 16, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SCYX | SCYNEXIS INC | Jun 26, 2025 | 2 | $0 | 4 | Jun 30, 2025 | Director |
| AKBA | Akebia Therapeutics, Inc. | Jun 10, 2025 | 2 | $0 | 4 | Jun 11, 2025 | Director |
| VCEL | Vericel Corp | Oct 16, 2024 | 3 | -$165K | 4 | Oct 18, 2024 | Director |
| VCEL | Vericel Corp | Oct 2, 2024 | 3 | -$159K | 4 | Oct 4, 2024 | Director |
| VCEL | Vericel Corp | Sep 18, 2024 | 3 | -$190K | 4 | Sep 20, 2024 | Director |
| VCEL | Vericel Corp | Sep 4, 2024 | 3 | -$224K | 4 | Sep 5, 2024 | Director |
| SCYX | SCYNEXIS INC | Jun 20, 2024 | 2 | $0 | 4 | Jun 21, 2024 | Director |
| AKBA | Akebia Therapeutics, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 10, 2024 | Director |
| VCEL | Vericel Corp | May 1, 2024 | 4 | $0 | 4 | May 3, 2024 | Director |
| SCYX | SCYNEXIS INC | Jun 15, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| SCYX | SCYNEXIS INC | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| AKBA | Akebia Therapeutics, Inc. | Jun 6, 2023 | 2 | $0 | 4 | Jun 8, 2023 | Director |
| VCEL | Vericel Corp | May 3, 2023 | 2 | $0 | 4 | May 5, 2023 | Director |
| VCEL | Vericel Corp | Apr 27, 2023 | 2 | $0 | 4 | Apr 28, 2023 | Director |
| SCYX | SCYNEXIS INC | Jun 17, 2022 | 2 | $0 | 4 | Jun 22, 2022 | Director |
| AKBA | Akebia Therapeutics, Inc. | Jun 8, 2022 | 2 | $0 | 4 | Jun 9, 2022 | Director |
| AKBA | Akebia Therapeutics, Inc. | Jun 3, 2022 | 1 | -$1.65K | 4 | Jun 7, 2022 | Director |
| CFRX | CONTRAFECT Corp | May 17, 2022 | 1 | $141K | 4 | May 18, 2022 | Director |
| VCEL | Vericel Corp | Apr 29, 2022 | 1 | -$27.8K | 4 | May 2, 2022 | Director |
| VCEL | Vericel Corp | Apr 27, 2022 | 4 | $0 | 4 | Apr 29, 2022 | Director |
| VCEL | Vericel Corp | Nov 29, 2021 | 3 | -$177K | 4 | Dec 1, 2021 | Director |
| VCEL | Vericel Corp | Oct 27, 2021 | 3 | -$234K | 4 | Oct 28, 2021 | Director |
| VCEL | Vericel Corp | Sep 30, 2021 | 3 | -$226K | 4 | Oct 1, 2021 | Director |
| SCYX | SCYNEXIS INC | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
| AKBA | Akebia Therapeutics, Inc. | Jun 7, 2021 | 1 | -$15.2K | 4 | Jun 9, 2021 | Director |
| AKBA | Akebia Therapeutics, Inc. | Jun 2, 2021 | 2 | $0 | 4 | Jun 3, 2021 | Director |
| CFRX | CONTRAFECT Corp | May 18, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |